Knowles Corporation

Knowles Corporation (KN) Market Cap

Knowles Corporation has a market capitalization of $3.13B.

Price: $36.59

0.51 (1.41%)

Market Cap: 3.13B

NYSE · time unavailable

CEO: Jeffrey S. Niew

Sector: Technology

Industry: Hardware, Equipment & Parts

IPO Date: 2014-02-14

Website: https://www.knowles.com

Knowles Corporation (KN) - Company Information

Market Cap: 3.13B|Sector: Technology

Company Profile

Knowles Corporation is a leading provider of specialized electronic components, offering an array of micro-acoustic microphones, sophisticated balanced armature speakers, comprehensive audio solutions, high-performance capacitors, and advanced radio frequency products. These precision technologies serve diverse industries, including consumer electronics, medical technology (medtech), defense, electric vehicles, industrial applications, and communications. The company operates through two distinct segments. Its Audio segment is dedicated to engineering and manufacturing innovative audio components, such as microphones, balanced armature speakers, and audio processors. These are integral to applications across mobile devices, hearing health solutions, True Wireless Stereo (TWS) products, the Internet of Things (IoT), and computing platforms. Concurrently, the Precision Devices (PD) segment focuses on the development and delivery of high-specification capacitor products and RF solutions. These critical components find use in demanding applications like power supplies, medical implants, satellite communications, radar systems, and general communications equipment. Knowles distributes its offerings directly to original equipment manufacturers (OEMs), their contract manufacturers, and suppliers, as well as through an established network of distributors. With a global footprint spanning Asia, the United States, Europe, and other parts of the Americas, the company, established in 1946, maintains its headquarters in Itasca, Illinois.

Analyst Sentiment

79%
Strong Buy

From 4 Active Polls

1Y Forecast: $40.67

▲ +11.2% Potential Upside

Consensus Target Metrics

Low Bound

$38

Median

$40

High Bound

$44

Average

$41

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$40.67
▲ +11.15% Upside
Low Target
$38.00
4% Risk
Median Target
$40.00
9% Mid
High Target
$44.00
20% Max
Consensus
Buy
7 / 15 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)3,1253,5552,1931,8392,0001,5311,3351,7721,599
Enterprise Value ($M)3,2263,6552,3041,9352,1221,6391,4421,8551,739
Price to Earnings Ratio (P/E)46.3245.0958.3621.4329.1449.05-826.0931.14142.64
Price/Earnings-to-Growth Ratio (PEG)5.043.526.074.7326.42
Price to Sales Ratio (P/S)4.9221.3114.3211.3413.0810.4910.1012.4311.22
Price to Book Ratio (P/B)3.944.472.812.372.662.051.772.342.06
Price to Free Cash Flow Ratio (P/FCF)49.22163.82-190.7057.6493.4648.92-494.2855.7232.57
Enterprise Value to Sales (EV/Sales)21.9215.0511.9313.8811.2310.9113.0212.21
Enterprise Value to EBITDA (EV/EBITDA)24.72105.65106.1647.6663.1571.57115.4069.7268.75
Debt to Equity Ratio0.770.190.190.190.290.280.280.280.30

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 KNOWLES CORP (KN) — Investment Overview

🧩 Business Model Overview

Knowles designs and manufactures acoustic and sensing components used inside communications and audio devices. The business typically operates through a “design-in → qualification → supply” value chain with major OEMs and tier-1 manufacturers across mobile, wearables, hearing health, and related electronics. Once components are selected for a device platform, Knowles supplies through recurring production programs tied to new product introductions, refresh cycles, and accessory ecosystems (e.g., wireless audio and hearing devices). The key economic feature is customer stickiness driven by validation requirements, performance specifications, and manufacturing process know-how.

💰 Revenue Streams & Monetisation Model

Knowles’ revenue is predominantly product-based (manufacturing and delivery of microphones, acoustic components, and related RF/audio/sensing offerings). Monetisation is driven by:
  • Platform-based demand: Device launches create volumes that roll through multiple production phases.
  • Mix shift to higher value components: Greater content per device and more complex technologies generally support better gross margin potential.
  • Manufacturing scale and yield: Utilization and yield improvements convert factory performance into margin expansion.
While revenue is not contractually recurring in the software sense, it is economically “sticky” because component qualification and performance requirements create repeat purchasing and longer vendor relationships across product cycles.

🧠 Competitive Advantages & Market Positioning

Knowles’ moat is best described as a combination of high switching costs and manufacturing/technology depth rather than a pure network effect.
  • Switching Costs (Design-in qualification): OEMs and tier-1 partners require engineering validation, acoustic/signal performance verification, reliability testing, and process consistency. Requalifying a new supplier typically implies non-trivial cost and schedule risk, which favors the incumbent design partner.
  • Intangible/Technical Barriers: Knowles’ know-how in acoustics, sensing, and related fabrication processes supports differentiated product performance and manufacturability—an edge competitors must replicate to displace designs.
  • Scale & Process Discipline: Competitors can offer “similar function” parts, but replicating yield, cost structure, and performance consistency at scale is difficult.
Competitive benchmarking:
  • AAC Technologies — Competes heavily in microphones and acoustic/sensor supply for consumer electronics; tends to be more focused on OEM phone ecosystem supply.
  • Goertek — Large supplier with broad audio and component capabilities; competes across microphones and audio-related components.
  • Sonion — Major competitor in hearing-related acoustic solutions; competes directly in hearing health content where performance and integration matter.
Knowles’ positioning versus rivals: Knowles emphasizes serving both hearing health and communications/audio platforms with components that benefit from qualification-led stickiness and repeat design programs. This portfolio breadth can diversify end-market exposure compared with more single-vertical competitors.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by end-market content expansion and device complexity:
  • Hearing health demand growth: Aging demographics and rising adoption of connected hearing devices expand the addressable market for acoustic and sensing components used in hearing aids.
  • Wireless audio and voice interface expansion: Microphones and acoustic components benefit from continued growth in earbuds, smart speakers, and voice-centric interfaces.
  • Sensing and user-experience features in consumer devices: Devices increasingly require higher fidelity audio pickup and better signal performance, supporting higher technical requirements per device.
  • Design wins tied to platform refresh cycles: While consumer electronics can be cyclical, technical specifications and qualification create a runway for new designs that can extend across multiple product generations.
The fundamental TAM driver is not only unit growth but also content-per-device and technology progression that increases the value of qualified suppliers.

⚠ Risk Factors to Monitor

  • Customer concentration and platform dependency: Revenue sensitivity to a limited set of large OEM/tier-1 customers can amplify demand swings.
  • Consumer electronics cyclicality: Inventory behavior and production pacing at OEMs can pressure volumes and utilization.
  • Technological substitution/commoditization: If performance requirements shift or alternative architectures emerge, designs can be displaced.
  • Manufacturing execution risk: Quality, yield, and supply continuity are critical—especially for components where reliability requirements are stringent.
  • Competitive pricing pressure: Successful qualification by rivals can lead to cost-down programs or mix dilution.
These risks are structural to hardware manufacturing supply chains and tend to be expressed through margin volatility and design timing rather than long-term impairment of the business model.

📊 Valuation & Market View

Markets often value companies in Knowles’ sector using a blend of EV/EBITDA and forward P/S, with valuation sensitivity to:
  • Gross margin sustainability: Mix improvements and yield discipline can support a premium.
  • Operating leverage: Factory utilization and cost absorption can drive earnings power.
  • Durability of design-in revenue: Evidence of ongoing platform participation and order stability influences multiples.
  • End-market mix: Hearing health exposure can be viewed as more defensive versus purely consumer cycle-driven segments.
In general, investors pay for a path to normalized profitability and continued design win momentum, rather than for short-term volume fluctuations.

🔍 Investment Takeaway

Knowles offers an investment profile anchored by qualification-driven switching costs and manufacturing/technology depth in acoustic and sensing components. The long-term thesis rests on the expansion of hearing health and wireless/voice-driven device ecosystems, where incumbency and performance validation create durable participation in platform life cycles. Key diligence focus should be on design win pipeline quality, manufacturing yield discipline, and resilience to consumer electronics cyclicality.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for KN.

seekingalpha.com2026-07-31

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

defenseworld.net2026-07-31

Bank of New York Mellon Corp Sells 32,082 Shares of Knowles Corporation $KN

Bank of New York Mellon Corp reduced its stake in shares of Knowles Corporation (NYSE: KN) by 5.6% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 543,697 shares of the communications equipment provider's stock after selling 32,082 shares during the period. Bank of New

zacks.com2026-07-29

All You Need to Know About Knowles (KN) Rating Upgrade to Strong Buy

Knowles (KN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

marketbeat.com2026-07-23

Knowles Q2 Earnings Call Highlights

Knowles NYSE: KN reported second-quarter 2026 results above its guidance range, with management pointing to broad-based demand across its Precision Devices business and steady performance in MedTech & Specialty Audio.

seekingalpha.com2026-07-23

Knowles Corporation (KN) Q2 2026 Earnings Call Transcript

Knowles Corporation (KN) Q2 2026 Earnings Call Transcript

zacks.com2026-07-23

Knowles (KN) Beats Q2 Earnings and Revenue Estimates

Knowles (KN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.24 per share a year ago.

businesswire.com2026-07-23

Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026

ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced results for the quarter ended June 30, 2026. “We delivered second quarter revenues exceeding the high end of our guided range. Non-GAAP diluted EPS was above the high end of our guided range and cash from operations was within t.

gurufocus.com2026-07-09

A Look at Knowles Corp (KN) After 6.3% Gain -- GF Value $23.60 vs Price $37.24

On July 09, 2026, Knowles Corp (KN) shares rose 6.3% to a current price of $37.24. Over the past year, the stock has seen substantial growth, achieving a remark

businesswire.com2026-07-01

Knowles to Release Second Quarter 2026 Financial Results on July 23, 2026

ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN) a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced the date for the release of its second quarter 2026 financial results. Second Quarter 2026 Conference Call and Webcast Knowles will issue its second quarter 2026 financial results on July 23, 2026, immediately after market closin.

zacks.com2026-06-24

Knowles Rides on Solid Demand for Voice-Enabled Devices: Worth Buying?

KN is riding the demand for voice-enabled devices, edge AI and IoT, as its audio tech, acquisitions and efficiency efforts support long-term growth.

fool.com2026-05-16

This Fund Added a New 5% Portfolio Position in a Surging Defense and Medtech Supplier

Knowles delivers micro-acoustic and precision device solutions to global OEMs across consumer, medical, and industrial markets.

gurufocus.com2026-05-13

Is Knowles Corp (KN) Overvalued After 3.9% Rally? GF Value Says Overvalued

On May 13, 2026, Knowles Corp (KN) shares rose 3.9% to $36.62, continuing a strong upward trend with a year-to-date increase of 70.9% and a 52-week range from $

seekingalpha.com2026-05-04

Diamond Hill Small Cap Strategy Q1 2026 Portfolio Review

Exploration and production company Magnolia Oil & Gas saw shares rise as the sharp increase in oil prices drove a broad rally across US-based oil producers. Red Rock Resorts' fundamentals remained solid, though the stock faced pressure in Q1 as investors linked gaming demand to discretionary spending trends. Recent Knowles' strategic initiatives have reshaped the portfolio toward higher-margin, mission-critical end markets with more durable demand drivers.

zacks.com2026-04-30

Are You Looking for a Top Momentum Pick? Why Knowles (KN) is a Great Choice

Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let's find out.

seekingalpha.com2026-04-23

Knowles Corporation (KN) Q1 2026 Earnings Call Transcript

Knowles Corporation (KN) Q1 2026 Earnings Call Transcript

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"KN delivered a mixed but improving Q2’26 despite weaker reported Revenue/Earnings line items in the dataset. Gross profit was $74.6M and operating income was $18.4M, with operating margin of ~12.0% (operating income $18.4M on gross profit $74.6M). Net income is shown as 0 in the Q2’26 fundamentals array, so Revenue and net-income growth are not computable from the provided Q2’26 fields; however, Q2’26 operating income and ebitda of $60.2M indicate profitability remained meaningful. QoQ, gross profit rose vs Q1’26 ($74.6M vs $63.2M), and operating income increased ($18.4M vs $16.1M). Compared with YoY Q2’25, operating income also appears higher (Q2’25 operating income $17.8M). Margins looked stable-to-up: operating income ratio improved vs Q1’26 (Q1 operating margin ~10.5%), though Q2 margins cannot be fully validated due to the missing/zero Revenue and net-income fields. Cash flow quality was solid: operating cash flow was $28.2M and free cash flow $21.7M in Q2’26, with working capital supporting cash generation. The balance sheet shows lower leverage: total assets rose modestly to $1.08B while equity increased to ~$0.80B, and net debt improved to ~$0.10B. Total shareholder returns are strong: the stock is up 108.35% YoY with positive 6-month and YTD momentum, supporting a high shareholder-return score despite the data limitations on reported net income."

Revenue Growth

Fair

Revenue for 2026-06-30 is reported as 0 in the dataset, so QoQ and YoY Revenue growth rates could not be reliably computed for the latest quarter.

Profitability

Positive

QoQ improvement in gross profit ($74.6M vs $63.2M) and operating income ($18.4M vs $16.1M). Net income and EPS are shown as 0 for 2026-06-30, limiting margin/EPS trend confirmation; operating income ratio vs gross profit suggests stable profitability.

Cash Flow Quality

Good

Operating cash flow was $28.2M and free cash flow $21.7M in Q2’26, supported by positive working capital change ($36.5M). Dividend payments are 0, and buybacks occurred (-$15M common stock repurchased).

Leverage & Balance Sheet

Positive

Total assets ~flat-to-up (Q2’26: $1.076B vs Q1’26: $1.054B). Equity improved to ~$0.796B. Net debt improved to ~$0.101B from ~$0.111B in Q1’26, indicating some balance-sheet resilience.

Shareholder Returns

Excellent

Price momentum is very strong: +108.35% over 1Y, +25.97% over 6M, +35.26% YTD. Buybacks were present in Q2’26; dividends are 0 in the dataset.

Analyst Sentiment & Valuation

Neutral

Consensus price target (~$38.5) is below the current price (~$29.69) in the provided fields, but the valuation metrics appear inconsistent across quarters; sentiment is therefore scored as moderate.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Knowles delivered a clearly upside Q2: $167M revenue (+14% YoY) and $0.33 EPS (+38% YoY), with cash from operations of $28M. The quality of growth sits in Precision Devices, where revenue rose 25% and gross margin expanded 140 bps to 40.1% on volume/utilization. PD book-to-bill of 1.4 marked the seventh straight quarter above 1, and management highlighted broad-based orders (~$140M core bookings in Q2) rather than one-off demand. Medtech & Specialty Audio also improved profitability (53.1% gross margin, +250 bps), though management flagged MSA sequential softness in Q4 from earlier inventory build. Guidance reinforces acceleration: 2026 revenue growth 10%–12% and adjusted EBITDA growth 20%–24%, plus Q3 EPS $0.34–$0.38 and adjusted EBIT margin of 22%–24%. Defense momentum stands out, with a $15M+ multiyear radar order beginning in 2027 and potential market acceleration over the next ~24 months.

AI IconGrowth Catalysts

  • Accelerated organic growth momentum: revenue up 14% YoY and EPS up 38% YoY, with management citing an “accelerated organic growth” period and robust backlog.
  • Precision Devices demand breadth and design wins across medtech, defense, industrial, and electrification; Q2 book-to-bill 1.4 (7th straight quarter >1).
  • Hearing Health (Medtech & Specialty Audio) strength within expected 2026 growth of 2%–4%, with potential improvement toward the 4% end-market range based on recent industry data.
  • Energy order ramp: delivered more than $5M in Q2 shipments; fully ramped into Q3 with yields better than planned.
  • Pricing power in PD supported by annual price actions, sole-source positioning, and improved capacity utilization/overhead absorption.

Business Development

  • Defense multiyear order: $15M+ radar application order received early July; expected to ship over ~36 months starting in 2027.
  • Industrial distribution/customer channels explicitly cited: TTI and Arrow Electronics (distribution partners) plus OEMs receiving broad-based demand.
  • Energy order referenced as a previously announced order (no named customer disclosed).

AI IconFinancial Highlights

  • Revenue $167M (+14% YoY), exceeding the high end of guided range.
  • EPS $0.33 (+38% YoY), above the high end of guided range.
  • Operating cash flow $28M, above midpoint of guidance.
  • Medtech & Specialty Audio revenue $69M (+2% YoY), slightly better than expected; gross margin not specified for this segment in the transcript.
  • Medtech & Specialty Audio gross margin 53.1% (+250 bps YoY) driven by factory productivity gains.
  • Precision Devices revenue $98M (+25% YoY); segment gross margin 40.1% (+140 bps YoY) driven by higher volume and capacity utilization.
  • Precision Devices gross margin improvement: >200 bps in 1H 2026; management expects further improvement in 2H via higher pricing, favorable mix, and increased utilization.
  • Q3 guidance revenue $167M–$177M (+12.5% YoY at midpoint).
  • Q3 adjusted EBIT margin guided at 22%–24%.
  • Q3 EPS guided $0.34–$0.38 (midpoint +9% YoY).
  • Q3 effective tax rate expected 15%–19%.
  • Capital structure/costs: interest expense in Q3 estimated $2M; Q2 interest expense down $1M YoY due to lower average debt.

AI IconCapital Funding

  • Share repurchase: 416,000 shares for $15M in Q2.
  • Cash/balance sheet: exited Q2 with cash $50M and $131M borrowings under revolving credit facility.
  • Liquidity: >$315M (cash plus unused revolver capacity).
  • Net leverage ratio: 0.5x on trailing 12-month adjusted EBITDA.
  • Debt reference from Q&A: “a little over $100M of debt at 5.25% interest” (used to frame EPS benefit from paydown).

AI IconStrategy & Ops

  • Strategy reiteration: provide high-value products tied to secular growth; leverage Micro Solutions group as a new growth platform (expected increased growth at historical rates).
  • Manufacturing improvements: Medtech segment gross margin expansion attributed to factory productivity gains; PD margin improvement attributed to production volume and factory capacity utilization.
  • Automation/capacity operations not explicitly described; instead, operational focus on capacity utilization and overhead absorption.
  • CapEx discipline: full-year capex expected ~5% of revenues, with investments in Precision Devices capacity to support increased customer demand; management indicated higher absolute capex due to higher revenue base.

AI IconMarket Outlook

  • Full-year 2026 revenue growth guidance: 10%–12% (accelerated vs Investor Day organic target 4%–6%).
  • Full-year adjusted EBITDA growth guidance: 20%–24% over 2025 levels.
  • Q3 2026 revenue: $167M–$177M; EPS $0.34–$0.38; operating cash flow $35M–$45M; capex $10M.
  • Back half gross margin expectation: PD gross margin expected in low 40% range for 2H 2026.
  • Hearing Health market outlook: expected 2%–4% growth in 2026; management notes recent hearing-aid industry data could imply closer to 4% end-market range.
  • Defense acceleration visibility: management expects possible acceleration of defense market around ~1 year from now (not immediate), driven by budget proposal/then timing into late 2027–2028 and stock replenishment ramp.

AI IconRisks & Headwinds

  • Hearing Health (MSA) sequential headwind in Q4 due to inventory building in the first half of the year (management expects MSA slower in Q4 while PD continues to grow).
  • Capacity risk avoidance: management is “cognizant” of not adding capacity for transient/commoditized orders while competitors may face long lead times; aims to avoid capacity for non-sustainable demand.
  • Defense spending timing uncertainty: acceleration depends on U.S. budget proposals and electronic warfare-related spend; management suggests increases may not show until late 2027–2028.
  • Near-term visibility sensitivity: management stated it is “a little too early to call” implications from newly released hearing-aid industry data.

Q&A: Analyst Interest

  • Q4 revenue cadence drivers and MSA vs PD sequencing: Management explained sequential Q3-to-Q4 growth with MSA headwind from “inventory building” in the first half, while PD continues growing at similar rates; they reiterated full-year 10%–12% confidence and noted hearing-aid data may push end-market near 4% growth.
  • PD bookings/cadence interpretation excluding energy and sustainable demand quality: Management clarified energy shipments were slightly more than $5M; energy book-to-bill was effectively zero because no new order was received. They emphasized ~$140M core orders in Q2 (vs just over $100M in Q1), broad-based by market/product/OEM vs distribution, and monitoring to avoid capacity for transient commodity demand.
  • Defense visibility and margin/price implications for next year: Management quantified defense mix (filters roughly $80M with ~90% defense; additional defense capacitor exposure). They described drivers (White House defense budget proposal timing, stock replacement 2–4x volumes, and allied procurement ramp) and framed pricing and lead-time effects that may shift price impact into next year, supporting further 2027 margin expansion.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the KN Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for KN.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (KN)

© 2026 Stock Market Info — Knowles Corporation (KN) Financial Profile